Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK)

Su-Ryang Kim1, Yoshiro Saito, Keiko Maekawa

  • 1Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan. kim@nihs.go.jp

Insights

This study identified 29 genetic variations in the deoxycytidine kinase (dCK) gene among Japanese cancer patients, including 20 novel variants. These findings highlight ethnic differences in dCK genetic makeup, crucial for cancer drug metabolism.

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Oncology

Background:

  • Deoxycytidine kinase (dCK) is essential for activating nucleoside anticancer drugs like gemcitabine.
  • Genetic variations in dCK can influence drug efficacy and patient response.
  • Understanding dCK genetic diversity is vital for personalized cancer therapy.

Purpose of the Study:

  • To comprehensively screen the deoxycytidine kinase (DCK) gene for genetic variations in Japanese cancer patients.
  • To identify novel genetic variations and analyze their frequencies.
  • To provide foundational data for DCK genotyping in Asian populations.

Main Methods:

  • Screening of the 5'-flanking region, 7 exons, and flanking introns of the DCK gene.
  • Genetic analysis of 256 Japanese cancer patients treated with gemcitabine.
  • Linkage disequilibrium analysis to identify haplotypes.

Main Results:

  • Twenty-nine genetic variations were identified in DCK, with twenty being novel.
  • Variations were found in the 5'-flanking region, UTRs, coding exon, and introns.
  • A known nonsynonymous SNP (364C>T) was detected at a frequency of 0.061, and 24 haplotypes were identified or inferred.

Conclusions:

  • Significant ethnic differences exist in DCK genetic variations.
  • The identified variations and haplotypes provide essential information for DCK genotyping in Japanese and potentially other Asian populations.
  • This research contributes to understanding the genetic basis of gemcitabine metabolism and response.

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genetic Variation01:25

Genetic Variation

Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles, which...